At Cigna Healthcare, 2026 will be a year defined by making healthcare simpler, more affordable and more intuitive for the ...
The top news to come out of skin cancer coverage this year for MHE focused on blood or marrow transplant recipients ...
The FDA issued a third complete response letter for ONS-5010/Lytenava, requesting confirmatory efficacy evidence for wet AMD treatment. Lytenava is an ophthalmic bevacizumab formulation, potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback